Literature DB >> 18164807

Field defects in progression to gastrointestinal tract cancers.

Carol Bernstein1, Harris Bernstein, Claire M Payne, Katerina Dvorak, Harinder Garewal.   

Abstract

A field of defective tissue may represent a pre-malignant stage in progression to many cancers. However, field defects are often overlooked in studies of cancer progression through assuming tissue at some distance from the cancer is normal. We indicate, however, the generality of field defects in gastrointestinal cancers, including cancers of the oropharynx, esophagus, stomach, bile duct, pancreas, small intestine and colon/rectum. Common features of these field defects are reduced apoptosis competence, aberrant proliferation and genomic instability. These features are often associated with high bile acid exposure and may explain the association of dietary-related factors with cancer progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164807      PMCID: PMC2744582          DOI: 10.1016/j.canlet.2007.11.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  68 in total

1.  The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.

Authors:  M P Bronner; C Culin; J C Reed; E E Furth
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

2.  Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives.

Authors:  I J Dhooge; M De Vos; P B Van Cauwenberge
Journal:  Laryngoscope       Date:  1998-02       Impact factor: 3.325

3.  Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid.

Authors:  B A Magnuson; N Shirtliff; R P Bird
Journal:  Carcinogenesis       Date:  1994-07       Impact factor: 4.944

4.  Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis.

Authors:  T A Brentnall; D A Crispin; M P Bronner; S P Cherian; M Hueffed; P S Rabinovitch; C E Rubin; R C Haggitt; C R Boland
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

5.  Multifocal accumulation of p53 protein in esophageal carcinoma: evidence for field cancerization.

Authors:  D Tian; Z Feng; N M Hanley; R W Setzer; J L Mumford; D M DeMarini
Journal:  Int J Cancer       Date:  1998-11-23       Impact factor: 7.396

Review 6.  Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis.

Authors:  C M Payne; H Bernstein; C Bernstein; H Garewal
Journal:  Ultrastruct Pathol       Date:  1995 Jul-Aug       Impact factor: 1.094

7.  Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk.

Authors:  H Garewal; H Bernstein; C Bernstein; R Sampliner; C Payne
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

8.  Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.

Authors:  K P Schepman; E H van der Meij; L E Smeele; I van der Waal
Journal:  Oral Oncol       Date:  1998-07       Impact factor: 5.337

Review 9.  Proliferation and differentiation biomarkers in colorectal mucosa and their application to chemoprevention studies.

Authors:  A Scalmati; M Lipkin
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

10.  Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?

Authors:  R K Ross; N M Hartnett; L Bernstein; B E Henderson
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

View more
  33 in total

1.  Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.

Authors:  Yan Gong; Ming-Zhou Guo; Zhi-Jia Ye; Xiu-Li Zhang; Yong-Liang Zhao; Yun-Sheng Yang
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.

Authors:  Helen Moinova; Rom S Leidner; Lakshmeswari Ravi; James Lutterbaugh; Jill S Barnholtz-Sloan; Yanwen Chen; Amitabh Chak; Sanford D Markowitz; Joseph E Willis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-07       Impact factor: 4.254

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

4.  Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells.

Authors:  Dhwanil Damania; Hemant K Roy; Dhananja Kunte; Jean A Hurteau; Hariharan Subramanian; Lusik Cherkezyan; Nela Krosnjar; Maitri Shah; Vadim Backman
Journal:  Int J Cancer       Date:  2013-04-01       Impact factor: 7.396

5.  Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer.

Authors:  Lisa A Lai; Rosa Ana Risques; Mary P Bronner; Peter S Rabinovitch; David Crispin; Ru Chen; Teresa A Brentnall
Journal:  Cancer Lett       Date:  2012-03-02       Impact factor: 8.679

6.  Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  John E Eaton; Emily G Barr Fritcher; Gregory J Gores; Elizabeth J Atkinson; James H Tabibian; Mark D Topazian; Andrea A Gossard; Kevin C Halling; Benjamin R Kipp; Konstantinos N Lazaridis
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

7.  Quantification of nanoscale density fluctuations by electron microscopy: probing cellular alterations in early carcinogenesis.

Authors:  Prabhakar Pradhan; Dhwanil Damania; Hrushikesh M Joshi; Vladimir Turzhitsky; Hariharan Subramanian; Hemant K Roy; Allen Taflove; Vinayak P Dravid; Vadim Backman
Journal:  Phys Biol       Date:  2011-03-25       Impact factor: 2.583

8.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Authors:  Nagaraj S Nagathihalli; Yugandhar Beesetty; Wooin Lee; M Kay Washington; Xi Chen; A Craig Lockhart; Nipun B Merchant
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

Review 9.  Role of interleukin-6 in Barrett's esophagus pathogenesis.

Authors:  Katerina Dvorak; Bohuslav Dvorak
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.